Detail akcie IQVIA Holdings Rg online

Business Summary: IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Iqvia Holdings Inc revenues increased 8% to $4.15B. Net income increased 10% to $274M. Revenues reflect Commercial Solutions segment increase of 12% to $1.75B, Research & Development Solutions segment increase of 6% to $2.4B, Americas segment increase of 10% to $1.98B, Europe & Africa Region segment increase of 11% to $1.36B, Asia Pacific Region segment increase of 2% to $812M.